Skip to main content

Table 4 Proportion of positive colorectal cancer screening tests

From: Colorectal cancer screening participation among citizens not recommended to be screened: a cohort study

Groups

Participants

FIT positive

Adjusted* OR

N

n

% (95% CI)

3)

Average risk

391,514

26,379

6.7 (6.7; 6.8)

1

1a)

CRC

1594

122

7.7 (6.4; 9.1)

0.949 [0.789; 1.142]

1b)

IBD with PSC

9

< 5**

NA

4.015 [0.826; 19.515]

1c)

Multiple polyps and polyps associated with hereditary CRC

151

20

13.2 (8.3; 19.7)

1.962 [1.234; 3.120]

2a)

Ulcerative colitis without PSC7

3808

562

14.8 (13.6; 15.9)

2.482 [2.267; 2.717]

2b)

Crohn's disease without PSC

1213

157

12.9 (11.1; 15.0)

2.181 [1.843; 2.581]

  1. FIT, faecal immunochemical test; CRC, colorectal cancer; IBD, inflammatory bowel disease (ulcerative colitis or Crohn's disease); PSC, primary sclerosing cholangitis
  2. *Adjusted for sex and 5-year age group, **Exact number not reported due to small number